3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
9
Head & Neck
2
Dermatologic
2
Breast
2
Sarcoma
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
6
Fallopian Tube Neoplasms
5
Uterine Cervical Neoplasms
4
Endometrial Neoplasms
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Peritoneal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Platinum-resistant Recurrent Ovarian Cancer
1
Neoplasm Metastasis
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Pancreatic Ductal
1
Interventions
pembrolizumab
14
Specimen Handling
8
Docetaxel
8
olaparib
7
Nivolumab
7
Gemcitabine
7
Trastuzumab
6
Paclitaxel
6
rucaparib
5
Magnetic Resonance Spectroscopy
5
Early Intervention, Educational
5
Biopsy
5
Standard of Care
4
Cyclophosphamide
4
Carboplatin
4
tisotumab vedotin
3
talazoparib
3
pertuzumab
3
durvalumab
3
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Sirolimus
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Methods
3
Irinotecan
3
Immunoglobulin G
3
Fulvestrant
3
Educational Status
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
tremelimumab
×
Gynecologic
×
Clear all
NCT03518606
2025-01-15
MOVIE
UNICANCER
Phase 1/2
Completed
126 enrolled